Correlation Between Curative Biotechnology and Viking Therapeutics
Can any of the company-specific risk be diversified away by investing in both Curative Biotechnology and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Curative Biotechnology and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Curative Biotechnology and Viking Therapeutics, you can compare the effects of market volatilities on Curative Biotechnology and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Curative Biotechnology with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Curative Biotechnology and Viking Therapeutics.
Diversification Opportunities for Curative Biotechnology and Viking Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Curative and Viking is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Curative Biotechnology and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Curative Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Curative Biotechnology are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Curative Biotechnology i.e., Curative Biotechnology and Viking Therapeutics go up and down completely randomly.
Pair Corralation between Curative Biotechnology and Viking Therapeutics
Given the investment horizon of 90 days Curative Biotechnology is expected to generate 10.03 times more return on investment than Viking Therapeutics. However, Curative Biotechnology is 10.03 times more volatile than Viking Therapeutics. It trades about 0.08 of its potential returns per unit of risk. Viking Therapeutics is currently generating about 0.06 per unit of risk. If you would invest 2.50 in Curative Biotechnology on November 9, 2024 and sell it today you would lose (1.25) from holding Curative Biotechnology or give up 50.0% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.74% |
| Values | Daily Returns |
Curative Biotechnology vs. Viking Therapeutics
Performance |
| Timeline |
| Curative Biotechnology |
| Viking Therapeutics |
Curative Biotechnology and Viking Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Curative Biotechnology and Viking Therapeutics
The main advantage of trading using opposite Curative Biotechnology and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Curative Biotechnology position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.| Curative Biotechnology vs. Biotron Limited | Curative Biotechnology vs. biOasis Technologies | Curative Biotechnology vs. Covalon Technologies | Curative Biotechnology vs. Mosaic Immunoengineering |
| Viking Therapeutics vs. Terns Pharmaceuticals | Viking Therapeutics vs. Akero Therapeutics | Viking Therapeutics vs. Madrigal Pharmaceuticals | Viking Therapeutics vs. Sarepta Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |